Will Senate Hearing Expose PBMs' Unscrupulous Drug Pricing Tactics?
 
Forbes | Sally Pipes
May 10, 2023

Sen. Bernie Sanders, I-Vt. hauled executives from three insulin manufacturers and three pharmacy benefit managers before the Senate Health, Education, Labor and Pensions Committee for a hearing on “the need to make insulin affordable for all Americans.”


Read more. . .

Thank the IRA for Cuts to Critical Drug Research
 
DC Journal | Sally Pipes
May 9, 2023

President Biden’s Inflation Reduction Act is just eight months old. It hasn’t yet slayed inflation. But it’s already gutting drug research and development.

The law gives Medicare the power to impose price controls on certain prescription drugs for the first time. By September, federal officials will select the first 10 medicines subject to price-setting from those covered by the Medicare Part D prescription drug program. The price caps for these drugs will go into effect in January 2026.


Read more. . .

The Continuing Danger From Progressive's Faulty Excess Profit Allegations
 
Forbes | Wayne Winegarden
May 15, 2023

During a May 11^th meeting of the Senate Health, Education, Labor and Pensions (HELP) committee, Sen. Sanders derided the profits of the U.S. pharmaceutical industry claiming, “Let’s not be naïve. The drug companies last year made $100 billion in profit. … Drug companies tell us that that money goes to research and development. More money went into stock buybacks, significantly more than research and development.”


Read more. . .

Wayne Winegarden Discusses America's Healthcare System on The Steve Hilton Show
 
The Steve Hilton Show | Wayne Winegarden
May 9, 2023

Steve has an extended chat with Wayne Winegarden of the Pacific Research Institute to discuss healthcare in America, why it’s broken, and how we can fix it.


Read more. . .